Quinidine-digoxin interaction: time course and pharmacokinetics

Area of Science:

• Pharmacology
• Clinical Pharmacy
• Cardiology

Background:

• Digoxin is a crucial medication for managing heart conditions.
• Quinidine is an antiarrhythmic drug that can interact with other medications.
• Understanding drug interactions is vital for patient safety and effective treatment.

Purpose of the Study:

• To investigate the impact of quinidine on digoxin pharmacokinetics.
• To quantify changes in digoxin serum levels and clearance during quinidine treatment.
• To determine if the quinidine dose affects its interaction with digoxin.

Main Methods:

• Studied 18 patients receiving digoxin and initiating quinidine therapy.
• Monitored serum digoxin concentrations over time.
• Conducted kinetic studies in normal volunteers receiving low-dose (800 mg/day) or high-dose (1,600 mg/day) quinidine.

Main Results:

• Serum digoxin levels significantly increased within 24 hours of starting quinidine, reaching a steady state in 48 hours.
• Quinidine reduced total digoxin clearance by 30-36%, renal clearance by 32-54%, and non-renal clearance by 22-29%.
• Reductions in digoxin volume of distribution and renal clearance were dose-dependent on quinidine levels; non-renal clearance changes were not.

Conclusions:

• Quinidine significantly alters digoxin pharmacokinetics, leading to higher serum concentrations.
• The interaction primarily involves reduced digoxin clearance, particularly renal clearance.
• Clinicians should closely monitor digoxin levels when initiating quinidine therapy due to this significant drug interaction.